Product Code: GVR-4-68039-951-5
Foam Dressing Market Growth & Trends:
The global foam dressing market size is expected to reach USD 2.52 billion by 2030, expanding at a CAGR of 4.73% from 2024 to 2030, according to a new report by Grand View Research, Inc. A few of the key drivers propelling the market growth include an increase in surgical cases, a rapidly aging population, and an increase in the number of diabetes patients. For instance, according to the World Economic Forum, the current population of Japanese people above 65 years of age is 25% of the total population. This number is further expected to rise to 40% by 2060. Older people are more likely to sustain wounds, thus, the market for foam dressing is expected to grow throughout the forecast period.
An increase in the number of obese/overweight people is another fueling factor of the market. For instance, according to an article by Sage Journals & Indian Academy of Neurosciences, 2021, the number of obese people in India is estimated to be 135 million. Similarly, as per the Obesity Evidence Hub, two-thirds of the Australian people, i.e., 35.6% are overweight, whereas, 31.3% are expected to be obese. These situations are anticipated to raise demand for bariatric treatments and other related surgeries, driving the growth of the market over the anticipated time frame.
Additionally, the industry is anticipated to grow in the upcoming years with the launch of the COVID-19 vaccine and the relaxation of lockdown restrictions. It is anticipated that many elective procedures will be performed that were delayed. Moreover, many top producers are engaged in strategic activities including new launches, partnerships, and geographic expansion that could enable them to profit from the rising demand for foam dressing products during the projection period. For instance, in February 2022, Medline Industries announced the launch of a new version of its foam dressing Optifoam Gentle EX Foam Dressing. This is specially designed to displace the pressure whenever used with a pressure injury prevention protocol. Thus, similar initiatives by other market players are anticipated to boost market growth during the post-pandemic time.
Foam Dressing Market Report Highlights:
- Based on type, the adhesive foam dressing segment dominated the market and accounted for a revenue share of 56.59% in 2023, owing to an increase in the number of high exudate wound patients
- Based on application, the chronic wound application segment accounted for a revenue share of 59.83% in 2023 and is leading the market
- Based on end-use, the hospital segment dominated the market, due to an increase in surgical site infections among hospital patients. On the other hand, during the projected period, the home healthcare segment is anticipated to witness the fastest CAGR over the forecast period
- North America dominated the market and accounted for the highest revenue share of 45.46% in 2023 owing to the increasing number of diabetic patients, rise in the number of obese population, and technological advancements
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Application
- 1.1.3. End-use
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Foam Dressing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing number of people suffering from chronic wounds
- 3.2.1.2. Increasing number of traumatic accidents
- 3.2.1.3. Increasing global geriatric population
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Availability of various substitute
- 3.2.2.2. Stringent regulations for foam dressings
- 3.3. Organoids & Spheroids Market Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Foam Dressing: Type Estimates & Trend Analysis
- 4.1. Foam Dressing Market: Type Movement Analysis
- 4.1.1. Adhesive Foam Dressing
- 4.1.1.1. Adhesive foam market estimates and forecast, 2018 - 2030
- 4.1.2. Non-adhesive Foam Dressing
- 4.1.2.1. Non-adhesive foam dressing market estimates and forecast, 2018 - 2030
Chapter 5. Foam Dressing: End-Use Estimates & Trend Analysis
- 5.1. Foam Dressing Market: End-Use Movement Analysis
- 5.1.1. Hospitals
- 5.1.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
- 5.1.2. Specialty clinics
- 5.1.2.1. Specialty clinics Institutes market estimates and forecast 2018 to 2030 (USD Million)
- 5.1.3. Home Healthcare
- 5.1.3.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
- 5.1.4. Others
- 5.1.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Foam Dressing: Application Estimates & Trend Analysis
- 6.1. Foam Dressing Market: Application Movement Analysis
- 6.1.1. Acute Wounds
- 6.1.1.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
- 6.1.1.2. Surgical & Traumatic Wounds
- 6.1.1.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 6.1.1.3. Burns
- 6.1.1.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
- 6.1.2. Chronic Wounds
- 6.1.2.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 6.1.2.2. Diabetic Foot Ulcers
- 6.1.2.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 6.1.2.3. Pressure Ulcers
- 6.1.2.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 6.1.2.4. Venous Leg Ulcers
- 6.1.2.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 6.1.2.5. Other Chronic Wounds
- 6.1.2.5.1. Other chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Foam Dressing Market: Regional Estimates & Trend Analysis
- 7.1. Global Regional Market Snapshot
- 7.2. North America
- 7.2.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Target Disease Prevalence
- 7.2.2.3. Competitive Scenario
- 7.2.2.4. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Target Disease Prevalence
- 7.2.3.3. Competitive Scenario
- 7.2.3.4. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.3. Europe
- 7.3.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.3.2. UK
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Target Disease Prevalence
- 7.3.2.3. Competitive Scenario
- 7.3.2.4. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Target Disease Prevalence
- 7.3.3.3. Competitive Scenario
- 7.3.3.4. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.3.4. France
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Target Disease Prevalence
- 7.3.4.3. Competitive Scenario
- 7.3.4.4. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Target Disease Prevalence
- 7.3.5.3. Competitive Scenario
- 7.3.5.4. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Target Disease Prevalence
- 7.3.6.3. Competitive Scenario
- 7.3.6.4. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.3.7. Denmark
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Target Disease Prevalence
- 7.3.7.3. Competitive Scenario
- 7.3.7.4. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Target Disease Prevalence
- 7.3.8.3. Competitive Scenario
- 7.3.8.4. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Target Disease Prevalence
- 7.3.9.3. Competitive Scenario
- 7.3.9.4. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.4.2. China
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Target Disease Prevalence
- 7.4.2.3. Competitive Scenario
- 7.4.2.4. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.4.3. Japan
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Target Disease Prevalence
- 7.4.3.3. Competitive Scenario
- 7.4.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Target Disease Prevalence
- 7.4.4.3. Competitive Scenario
- 7.4.4.4. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.4.5. Australia
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Target Disease Prevalence
- 7.4.5.3. Competitive Scenario
- 7.4.5.4. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.4.6. Thailand
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Target Disease Prevalence
- 7.4.6.3. Competitive Scenario
- 7.4.6.4. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.4.7. South Korea
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Target Disease Prevalence
- 7.4.7.3. Competitive Scenario
- 7.4.7.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.5. Latin America
- 7.5.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Target Disease Prevalence
- 7.5.2.3. Competitive Scenario
- 7.5.2.4. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.5.3. Mexico
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Target Disease Prevalence
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.5.4. Argentina
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Target Disease Prevalence
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.6. MEA
- 7.6.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.6.2. Saudi Arabia
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Target Disease Prevalence
- 7.6.2.3. Competitive Scenario
- 7.6.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.6.3. South Africa
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Target Disease Prevalence
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Target Disease Prevalence
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Target Disease Prevalence
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key Company Market Share Analysis, 2022
- 8.3.4. 3M
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. COLOPLAST CORP
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. MEDLINE INDUSTRIES
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. SMITH & NEPHEW
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. CARDINAL HEALTH
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. CONVATEC GROUP PLC
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. DERMA SCIENCES (INTEGRA LIFESCIENCES)
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. ETHICON (JOHNSON & JOHNSON)
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. MCKESSON CORPORATION
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. MOLNLYCKE HEALTH CARE AB
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives